Tag: Novo Nordisk A/S

December 27, 2025

Novo Nordisk’s GLP-1 Pill Approved by FDA for Obesity

December 22, 2025

Nine Pharma Companies Ink Deals to Lower Drug Prices

December 18, 2025

Eli Lilly Obesity Pill Keeps Weight Loss After Wegovy, Zepbound

December 11, 2025

Retatrutide: Eli Lilly Weight Loss Drug Shows Promise in Late-Stage Trial

December 1, 2025

Eli Lilly Cuts Cash Prices of Zepbound Weight Loss Drug Vials

November 28, 2025

European Markets Rise; Delivery Hero Soars

November 18, 2025

European Stock Market Indices: Stoxx 600, FTSE, DAX, CAC

November 10, 2025

AI Wobble Shadows ‘Davos for Geeks

November 9, 2025

Trump Strikes Deal with Eli Lilly, Novo Nordisk

November 8, 2025

Trump Deals with Lilly, Novo Nordisk Broadens Obesity Drug Access

November 5, 2025

Novo Nordisk Sales Outlook Downgraded: Pfizer Bid for Metsera Intensifies

November 5, 2025

Novo Nordisk Q3 Earnings: Wegovy, Ozempic Shares Decline

November 3, 2025

Weight Loss Drugs: Trends, Competition, and Insurance Coverage

November 2, 2025

Novo Nordisk: Past Peak Uncertainty?

October 18, 2025

Lilly Novo Nordisk Stock Drop: Trump GLP-1 Price Remarks

October 17, 2025

Stock Market Today: Live Updates